Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
China real-world study of Austedo for adult tardive dyskinesia
CTR20210396Phase 4Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of deutetrabenazine in tardive dyskinesia (TD), sponsored by Teva Pharmaceutical Industries Ltd.. Started Nov 2023; status: completed.
02
Drugs
deutetrabenazine
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on CTR20210396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210396.